2026 年至 2032 年外科和感染控制设备市场（按产品类型、应用、最终用户和地区）

外科和感染控制设备市场评估 - 2026-2032

预计 2024 年市场规模将达到 2,218.3 亿美元，2032 年将达到 3,397.8 亿美元，2026 年至 2032 年的复合年增长率为 5.6%。

这种增长背后有多种因素，包括技术进步、外科手术数量的增加、感染控制意识的提高等。在外科手术和感染控制设备的不断发展的支持下，预计整个预测期内将稳步扩张。

外科和感染控制设备市场定义/概述

外科手术和感染控制设备涵盖了用于实施手术和防止感染传播的各种设备。外科手术设备包括手术刀、腹腔镜器械，甚至包括机器人系统，用于辅助精准、微创的手术，从而促进患者快速康復。

感染控制设备，包括消毒剂、灭菌器和个人防护设备，用于保护病人和医护人员免受有害病原体的侵害。这些设备具有显着的优点：手术器械可最大限度地减少组织破坏，使手术更有效；而感染控制措施则能创造更安全的环境，减少医院内感染，并改善病患预后。

技术进步在推动外科和感染控制设备市场成长方面发挥什么关键作用？

技术进步发挥着至关重要的作用，不断的创新推动更先进、更有效率的手术和感染控制设备的开发。这些进步提高了手术的有效性、安全性和精准度，从而促进了市场的成长。

此外，慢性病的日益普及和老年人口的不断增长，也刺激了外科手术的需求，从而推动了外科手术器械的普及。另一个关键驱动因素是医护人员和病患对感染控制意识的不断增强。

院内感染 (HAI) 和手术部位感染 (SSI) 的增多，促使人们更加重视实施严格的感染控制通讯协定。这导致对灭菌器、消毒剂和个人防护设备(PPE) 等感染控制设备的需求激增。旨在确保病患安全和维持高标准感染控制的监管措施正在影响市场动态。

医疗保健基础设施的不断扩张，尤其是在新兴经济体，为外科和感染控制设备市场提供了丰厚的成长机会。快速的都市化、不断增长的医疗支出以及医疗服务可近性的改善，正在推动先进医疗技术的普及，包括外科和感染控制设备。

此外，门诊手术趋势的兴起和门诊手术中心（ASC）的建立，满足了日益增长的微创手术需求，也促进了市场的扩张。此外，对预防性医疗保健措施和卫生习惯推广的日益重视也推动了市场的发展。全球各地的医疗保健组织和政府正在进行公共卫生宣传活动和倡议，向公众宣传感染预防和控制的重要性。这种日益增强的意识推动了感染控制设备的采用，鼓励医疗机构投资最先进的设备，以确保病患安全并最大限度地降低感染风险。这些因素共同推动市场持续扩张，并有望在短期内带来进一步的成长机会。

是什么原因导致手术和感染控制设备销售突然下降？

导致外科和感染控制设备市场销售额急剧下降的因素有几个。其中一个关键因素是替代治疗方案和治疗方法的出现，将注意力和资源从传统的外科手术介入上转移开。这些替代疗法提供侵入性较小的方法，患者和医疗保健提供者可能认为它们更安全、更具成本效益。因此，随着医疗保健偏好转向非手术解决方案，对外科设备的需求正在下降。全球景气衰退和医疗保健系统的预算限制给医院和医疗机构带来了削减开支的压力。这导致人们谨慎购买新的医疗设备，包括外科和感染控制设备。此外，报销挑战和不断变化的医疗保健政策增加了市场的不确定性，进一步阻碍了销售成长。

门诊护理和微创手术的日益普及正在影响传统手术设备的需求。门诊手术成本更低、恢復时间更短，对患者和医疗服务提供者都有好处。因此，传统住院环境中使用的复杂手术设备的需求减少，导致销售下降。公共卫生倡议和宣传宣传活动鼓励人们养成更健康的生活方式和习惯，以预防疾病和感染疾病。这种积极主动的医疗保健方式可能会减少对手术干预和感染控制设备的需求，从而导致市场销售下降。

此外，医疗保健领域日益严格的监管审查和合规要求也给外科和感染控制设备製造商带来了挑战。严格的产品安全、功效和品质保证法规要求企业在研发和合规方面投入大量资金，这可能会阻碍市场参与企业，并影响收入成长。

目录

第 1 章全球外科与感染控制设备市场简介

• 市场概览
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章 外科手术与感染控制设备的全球市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

第五章全球外科和感染控制设备市场（依产品类型）

• 概述
• 消毒剂
• 消毒洗手液
• 皮肤消毒剂
• 手术服
• 外科用覆盖巾
• 皮肤准备液
• 医用不织布
• 手术手套
• 其他的

第六章全球外科和感染控制设备市场（按应用）

• 概述
• 一般外科
• 整形外科
• 心血管外科
• 神经外科
• 整形外科

第七章全球外科和感染控制设备市场（按最终用户）

• 概述
• 医院
• 门诊手术中心

第八章全球外科和感染控制设备市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 其他的
  • 拉丁美洲
  • 中东和非洲

第九章全球外科和感染控制设备市场的竞争格局

• 概述
• 各公司市场排名
• 重点发展策略

第十章 公司简介

• Belimed
• Biomerieux
• Getinge
• Johnson & Johnson
• Kimberly-Clark
• Sotera Health
• Ansell Limited
• Steris
• Lac-Mac
• Pacon Manufacturing
• 3M, BD
• American Polyfilm

第十一章 公司简介 附录

• 相关调查

Surgical and Infection Control Devices Market Valuation - 2026-2032

In 2024, the surgical and infection control devices market size was estimated at USD 221.83 Billion, with a projected increase to USD 339.78 Billion by 2032, reflecting a CAGR of 5.6% from 2026 to 2032.

This growth is driven by various factors, including technological advancements, increasing surgical procedures, and rising awareness of infection control measures. Throughout the forecast period, steady expansion is anticipated, underpinned by the continuous development of surgical and infection control devices.

Surgical and Infection Control Devices Market: Definition/Overview

Surgical and infection control devices encompass a vast array of equipment used to perform surgeries and prevent the spread of infections. Surgical devices include scalpels, laparoscopic instruments, and even robotic systems, facilitating precise and minimally invasive procedures for faster recovery.

Infection control devices, like disinfectants, sterilization equipment, and personal protective equipment, are employed to safeguard patients and healthcare workers from harmful pathogens. These devices offer significant advantages. Surgical instruments enable more effective procedures with minimal tissue disruption, while infection control measures create a safer environment, reducing hospital-acquired infections and improving patient outcomes.

What Significant Role Have Advancements in Technology Played in Driving the Growth of the Surgical and Infection Control Devices Market?

Technological advancements are playing a pivotal role, with continuous innovations leading to the development of more advanced and efficient surgical and infection control devices. These advancements are enhancing the efficacy, safety, and precision of surgical procedures, thus contributing to market growth.

Moreover, the increasing prevalence of chronic diseases and the growing geriatric population are fueling the demand for surgical interventions, consequently boosting the adoption of surgical devices. Another significant driver is the rising awareness of infection control measures among healthcare professionals and patients.

With the increasing incidence of hospital-acquired infections (HAIs) and surgical site infections (SSIs), there is a heightened focus on implementing stringent infection control protocols. This has led to a surge in the demand for infection control devices such as sterilization equipment, disinfectants, and personal protective equipment (PPE). Regulatory initiatives aimed at ensuring patient safety and maintaining high standards of infection control are influencing market dynamics.

The expanding healthcare infrastructure, particularly in emerging economies, is providing lucrative growth opportunities for the surgical and infection control devices market. Rapid urbanization, increasing healthcare expenditure, and improving access to healthcare services are driving the adoption of advanced medical technologies, including surgical and infection control devices.

Furthermore, the growing trend of outpatient surgeries and the establishment of ambulatory surgical centers (ASCs) are contributing to market expansion by catering to the rising demand for minimally invasive procedures. The market is also benefiting from the growing emphasis on preventive healthcare measures and the promotion of good hygiene practices. Healthcare organizations and governments worldwide are implementing public health campaigns and initiatives to educate the population about the importance of infection prevention and control. This heightened awareness is driving the adoption of infection control devices and encouraging healthcare facilities to invest in state-of-the-art equipment to ensure patient safety and minimize the risk of infections. These factors collectively contribute to the continued expansion of the market, with opportunities for further growth expected in the foreseeable future.

What Factors are Plummeting Sales of the Surgical and Infection Control Devices Market?

Several factors are contributing to the plummeting sales of the surgical and infection control devices market. One significant factor is the emergence of alternative treatment options and therapies, which are diverting attention and resources away from traditional surgical interventions. These alternatives offer less invasive approaches and may be perceived as safer or more cost-effective by patients and healthcare providers alike. Consequently, the demand for surgical devices is diminishing as healthcare preferences shift towards non-surgical solutions. Economic downturns and budget constraints in healthcare systems worldwide are exerting pressure on hospitals and medical facilities to reduce expenditures. This has led to a cautious approach towards purchasing new medical equipment, including surgical and infection control devices. Additionally, reimbursement challenges and changes in healthcare policies are contributing to uncertainty in the market, further impeding sales growth.

The increasing trend towards outpatient care and minimally invasive procedures is impacting the demand for traditional surgical devices. Outpatient surgeries offer cost savings and shorter recovery times, making them preferable for patients and healthcare providers. Consequently, there is a reduced need for complex surgical equipment traditionally used in inpatient settings, leading to a decline in sales. Public health initiatives and awareness campaigns are encouraging individuals to adopt healthier lifestyles and practices to prevent diseases and infections. This proactive approach to healthcare may reduce the need for surgical interventions and infection control devices, thereby contributing to declining sales in the market.

Furthermore, the regulatory scrutiny and compliance requirements in the healthcare sector are increasing, posing challenges for manufacturers of surgical and infection control devices. Strict regulations regarding product safety, efficacy, and quality assurance necessitate significant investments in research, development, and regulatory compliance, which may deter market players and hinder sales growth.

Category-Wise Acumens

Which Product Type Category Holds the Dominant Market Share in the Surgical and Infection Control Devices Market?

In the surgical and infection control devices market, the dominant market share is held by surgical devices. A wide range of instruments and equipment used in various surgical procedures across different medical specialties is encompassed by surgical devices. A crucial role is played by these devices in facilitating surgical interventions, enhancing procedural efficiency, and ensuring optimal patient outcomes. With the rising prevalence of chronic diseases, advancements in medical technology, and expanding healthcare infrastructure, there has been a significant uptick in the demand for surgical interventions. The adoption of surgical devices, including instruments, equipment, and consumables, is driven by this heightened demand, thereby consolidating the market share of this product category.

Additionally, technological advancements and innovations in surgical devices are bolstering their market position. More advanced and specialized surgical instruments and equipment have been introduced as a result of continuous research and development efforts. These innovations focus on improving surgical precision, minimizing invasiveness, and enhancing patient safety, thereby increasing the appeal and adoption of surgical devices among healthcare providers.

The demand for specialized surgical devices tailored for these procedures is driven by the growing trend towards minimally invasive surgeries (MIS). Several advantages over traditional open surgeries, including reduced post-operative pain, shorter hospital stays, and faster recovery times, are offered by minimally invasive techniques. Consequently, increased utilization of minimally invasive surgical devices and contribution to the dominant market share of surgical devices has led to a growing preference for MIS among both patients and surgeons.

Furthermore, a higher volume of surgical interventions is necessitated by the expanding geriatric population and the increasing prevalence of age-related conditions. A critical role in addressing the healthcare needs of elderly patients, including those undergoing joint replacements, cardiac surgeries, and other procedures commonly performed in this demographic group, is played by surgical devices. As the elderly population continues to grow globally, the demand for surgical devices is expected to remain robust, further solidifying their dominant market share.

Will the Orthopedic Surgery Segment Turn into an Epicenter of Growth in the Surgical and Infection Control Devices Market?

The demand for orthopedic surgical interventions is being driven by the escalating prevalence of musculoskeletal disorders and injuries worldwide. An aging population and increasing incidence of conditions such as osteoarthritis, fractures, and sports injuries are observed, leading to a growing need for orthopedic surgeries to restore mobility, alleviate pain, and improve quality of life. It is expected that this rising demand for orthopedic procedures will fuel the adoption of surgical and infection control devices tailored for orthopedic surgery.

Additionally, innovations such as minimally invasive surgery, computer-assisted navigation, and 3D printing are enabling surgeons to perform more precise, customized, and effective interventions. As orthopedic surgeons embrace these advancements to enhance patient outcomes and surgical efficiency, there is a corresponding increase in the utilization of specialized orthopedic devices, including implants, instruments, and infection control solutions.

Stringent requirements for the safety, efficacy, and quality assurance of orthopedic devices are being imposed by regulatory agencies and healthcare authorities. Compliance with these regulations necessitates continuous innovation, research, and development by manufacturers, driving investment in advanced orthopedic surgical and infection control technologies. Moreover, the role of orthopedic surgery as a growth epicenter in the surgical and infection control devices market is further amplified by the expanding application of orthopedic surgery across diverse patient populations and medical specialties. Not only traditional joint replacements but also spine surgery, trauma surgery, sports medicine, and orthobiologics are encompassed by orthopedic procedures. This broadening scope of orthopedic interventions increases the demand for a comprehensive range of surgical and infection control devices tailored to specific orthopedic applications and patient needs. Therefore, the orthopedic surgery segment is poised to emerge as a central driver of growth in the surgical and infection control devices market.

Country/Region Wise Acumens

Could North America Drive an Increase in Sales within the Surgical and Infection Control Devices Market?

Advanced healthcare infrastructure and significant investments in medical technologies characterize the region, positioning North America as a key market for surgical and infection control devices. Stringent regulatory standards and a strong emphasis on patient safety in North America necessitate the continuous development and adoption of advanced medical devices, including those used in surgical procedures and infection control. Compliance with these regulations requires manufacturers to invest in research, development, and quality assurance measures, thereby driving sales growth within the market.

Moreover, the rising demand for surgical interventions is contributed to by the increasing prevalence of chronic diseases and the aging population in North America. The incidence of conditions such as cardiovascular diseases, orthopedic disorders, and cancer is observed to escalate, leading to a corresponding increase in the need for surgical procedures and related medical devices. This trend fuels the demand for surgical and infection control devices, potentially leading to an increase in sales.

Sales growth within the surgical and infection control devices market in North America is significantly driven by technological advancements and innovations. The region is known for its robust healthcare research and development ecosystem, leading to the continuous introduction of cutting-edge medical technologies. Advancements such as robotic-assisted surgery, minimally invasive techniques, and advanced sterilization methods are observed to enhance the efficacy, precision, and safety of surgical procedures. As these innovations are embraced by healthcare providers in North America to improve patient outcomes and operational efficiency, there is a corresponding surge in the adoption of associated medical devices, further driving sales within the market. In conclusion, North America's advanced healthcare infrastructure, regulatory standards, demographic trends, and technological innovations, collectively position the region to drive an increase in sales within the surgical and infection control devices market.

Will the Sales of the Surgical and Infection Control Devices Market fare well in Asia Pacific?

Rapid economic growth and development in Asia Pacific lead to an expansion of healthcare infrastructure and an increase in healthcare expenditure. Consequently, significant growth opportunities are presented for the surgical and infection control devices market in the region. Additionally, the demand for surgical interventions and infection control measures is fueled by the increasing prevalence of chronic diseases and infectious conditions in Asia Pacific, thereby driving sales within the market. A surge in the adoption of advanced medical technologies, including minimally invasive surgical techniques, robotic-assisted surgery, and state-of-the-art sterilization equipment, is being witnessed in the region. The efficacy, safety, and precision of surgical procedures are enhanced by these innovations, contributing to the growth of the market and fostering a favorable environment for sales expansion.

Furthermore, heightened attention towards implementing stringent infection control protocols and investing in infection control devices, such as sterilization equipment, disinfectants, and personal protective equipment, is observed due to the increasing incidence of hospital-acquired infections and surgical site infections. This heightened awareness stimulates the demand for infection control solutions, consequently boosting sales within the market. Lucrative growth opportunities for the surgical and infection control devices market are provided by the expanding healthcare infrastructure and rising healthcare expenditure in emerging economies across Asia Pacific. Market expansion in the region is further contributed to by rapid urbanization, increasing access to healthcare services, and a growing emphasis on preventive healthcare measures.

Moreover, the market dynamics are influenced by regulatory initiatives aimed at ensuring patient safety and maintaining high standards of infection control, fostering a conducive environment for sales growth in Asia Pacific. Overall, it is expected that the sales of the Surgical and Infection Control Devices Market will fare well in Asia Pacific, driven by factors such as economic growth, technological advancements, increasing prevalence of diseases, growing awareness of infection control measures, expanding healthcare infrastructure, and regulatory initiatives.

Competitive Landscape

Analyzing the competitive landscape of the surgical and infection control devices market is crucial for gaining insights into the industry's dynamics. This research aims to delve into the competitive landscape, focusing on key players, market trends, innovations, and strategies. By conducting this analysis, valuable insights will be provided to industry stakeholders, assisting them in navigating the competitive environment adeptly and seizing emerging opportunities. Understanding the competitive landscape will enable stakeholders to make informed decisions, align with market trends, and formulate strategies to strengthen their market position and competitiveness in the surgical and infection control devices market.

Some of the prominent players operating in the surgical and infection control devices market include:

• 3M, BD
• Belimed
• Biomerieux
• Getinge
• Kimberly-Clark
• Sotera Health
• Ansell Limited
• Steris
• Lac-Mac
• Pacon Manufacturing
• American Polyfilm

Latest Developments

• In November 2020, the launch of AppliFlex ST, a customizable single-use bioreactor optimizing processes and reducing labor hours in the lab, was announced by Applicon Biotechnology, a division of Getinge.
• In January 2021, the acquisition of Cantel Medical, a global provider of products preventing infection and providing services to dialysis, dental, endoscopy, and life sciences customers, was announced by Steris.

Surgical and Infection Control Devices Market, By Category

• Product Type
• Surgical Devices
• Surgical Sutures and Staples
• Handheld Surgical Instruments
• Electrosurgical Devices
• Surgical Power Tools
• Surgical Suction Devices
• Infection Control Devices
• Sterilization Equipment
• Disinfectants
• Personal Protective Equipment
• Application
• General Surgery
• Orthopedic Surgery
• Cardiovascular Surgery
• Neurosurgery
• Plastic Surgery
• End-User
• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL SURGICAL AND INFECTION CONTROL DEVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL SURGICAL AND INFECTION CONTROL DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL SURGICAL AND INFECTION CONTROL DEVICES MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Disinfectants
• 5.3 Hand Disinfectants
• 5.4 Skin Disinfectants
• 5.5 Surgical Scrubs
• 5.6 Surgical Drapes
• 5.7 Skin Preparation Solution
• 5.8 Medical Nonwovens
• 5.9 Surgical Gloves
• 5.10 Others

6 GLOBAL SURGICAL AND INFECTION CONTROL DEVICES MARKET, BY Application

• 6.1 Overview
• 6.2 General Surgery
• 6.3 Orthopedic Surgery
• 6.4 Cardiovascular Surgery
• 6.5 Neurosurgery
• 6.6 Plastic Surgery

7 GLOBAL SURGICAL AND INFECTION CONTROL DEVICES MARKET, BY END-USERS

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Ambulatory Surgical Centers

8 GLOBAL SURGICAL AND INFECTION CONTROL DEVICES MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East & Africa

9 GLOBAL SURGICAL AND INFECTION CONTROL DEVICES MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Belimed
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Biomerieux
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Getinge
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Johnson & Johnson
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Kimberly-Clark
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Sotera Health
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Ansell Limited
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Steris
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Lac-Mac
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Pacon Manufacturing
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments
• 10.11 3M, BD
  • 10.11.1 Overview
  • 10.11.2 Financial Performance
  • 10.11.3 Product Outlook
  • 10.11.4 Key Developments
• 10.12 American Polyfilm
  • 10.12.1 Overview
  • 10.12.2 Financial Performance
  • 10.12.3 Product Outlook
  • 10.12.4 Key Developments

11 APPENDIX

• 11.1 Related Research